35 related articles for article (PubMed ID: 7750217)
1. In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma.
Ritchie D; Mileshkin L; Wall D; Bartholeyns J; Thompson M; Coverdale J; Lau E; Wong J; Eu P; Hicks RJ; Prince HM
Cancer Immunol Immunother; 2007 Feb; 56(2):155-63. PubMed ID: 16733671
[TBL] [Abstract][Full Text] [Related]
2. Radiolabeled Antibodies for Cancer Imaging and Therapy.
Parakh S; Lee ST; Gan HK; Scott AM
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326605
[TBL] [Abstract][Full Text] [Related]
3. TAG-72-Targeted α-Radionuclide Therapy of Ovarian Cancer Using
Minnix M; Li L; Yazaki PJ; Miller AD; Chea J; Poku E; Liu A; Wong JYC; Rockne RC; Colcher D; Shively JE
J Nucl Med; 2021 Jan; 62(1):55-61. PubMed ID: 32620701
[TBL] [Abstract][Full Text] [Related]
4. Improved targeting of an anti-TAG-72 antibody drug conjugate for the treatment of ovarian cancer.
Minnix M; Li L; Yazaki P; Chea J; Poku E; Colcher D; Shively JE
Cancer Med; 2020 Jul; 9(13):4756-4767. PubMed ID: 32368864
[TBL] [Abstract][Full Text] [Related]
5. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer.
Flanagan FL; Dehdashti F; Ogunbiyi OA; Kodner IJ; Siegel BA
Ann Surg; 1998 Mar; 227(3):319-23. PubMed ID: 9527052
[TBL] [Abstract][Full Text] [Related]
6. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.
Rigo P; Paulus P; Kaschten BJ; Hustinx R; Bury T; Jerusalem G; Benoit T; Foidart-Willems J
Eur J Nucl Med; 1996 Dec; 23(12):1641-74. PubMed ID: 8929320
[TBL] [Abstract][Full Text] [Related]
7. OncoScint CR103 imaging in the surgical management of patients with colorectal cancer.
Doerr RJ; Abdel-Nabi HH
Targeted Diagn Ther; 1992; 6():89-109. PubMed ID: 1576352
[No Abstract] [Full Text] [Related]
8. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.
Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP
Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunodetection of colorectal carcinoma.
Artiko V; Obradovic V; Davidovic B; Petrovic N; Petrovic M; Krivokapic Z; Kecmanovic D; Pesko P; Djukic V; Milosavljevic T; Adanja G; Vlajkovic M
Hepatogastroenterology; 2003; 50(52):1029-31. PubMed ID: 12845972
[TBL] [Abstract][Full Text] [Related]
10. [Indium 111-labeled antibodies in the detection of colorectal carcinoma].
Artiko V; Obradović V; Davidović B; Petrović N; Petrović M; Krivokapić Z; Pavlov M; Adanja G; Sobić D; Vlajković M; Pavlović S; Rebić R
Acta Chir Iugosl; 2003; 50(4):43-6. PubMed ID: 15307496
[TBL] [Abstract][Full Text] [Related]
11. Role of In-111 labeled CYT-103 immunoscintigraphy in the evaluation of patients with recurrent colorectal carcinoma.
Markowitz A; Saleemi K; Freeman LM
Clin Nucl Med; 1993 Aug; 18(8):685-700. PubMed ID: 8403703
[TBL] [Abstract][Full Text] [Related]
12. Oncoscint for detection of disseminated colorectal and ovarian cancer.
Med Lett Drugs Ther; 1993 Jun; 35(898):52-3. PubMed ID: 8497207
[No Abstract] [Full Text] [Related]
13. Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations.
Bohdiewicz PJ; Scott GC; Juni JE; Fink-Bennett D; Wilner F; Nagle C; Dworkin HJ
Clin Nucl Med; 1995 Mar; 20(3):230-6. PubMed ID: 7750217
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
